REFERENCES:
1. Birnkrant D, Bushby K, Bann C et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.The Lancet Neurology . 2018;17(3):251-267. doi:10.1016/s1474-4422(18)30024-3
2. Araujo A, Carvalho A, Cavalcanti E et al. Brazilian consensus on Duchenne muscular dystrophy. Part 1: diagnosis, steroid therapy and perspectives.Arq Neuropsiquiatr . 2017;75(8):104-113. doi:10.1590/0004-282x20170112
3. Mayer O. Pulmonary function and clinical correlation in DMD.Paediatr Respir Rev . 2018;30:13-15. doi:10.1016/j.prrv.2018.08.003
4. Aliverti A, LoMauro A, D’Angelo M. Assessment and management of respiratory function in patients with Duchenne muscular dystrophy: current and emerging options.Ther Clin Risk Manag . 2015:1475. doi:10.2147/tcrm.s55889
5. Finder J, Mayer O, Sheehan D et al. Pulmonary Endpoints in Duchenne Muscular Dystrophy. A Workshop Summary.Am J Respir Crit Care Med . 2017;196(4):512-519. doi:10.1164/rccm.201703-0507ws
6. Birnkrant D, Bushby K, Bann C et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.The Lancet Neurology . 2018;17(4):347-361. doi:10.1016/s1474-4422(18)30025-5
7. Mayer O, Finkel R, Rummey C et al. Characterization of pulmonary function in Duchenne Muscular Dystrophy.Pediatr Pulmonol . 2015;50(5):487-494. doi:10.1002/ppul.23172
8. Fox H, Millington L, Mahabeer I, van Ruiten H. Duchenne muscular dystrophy.BMJ . 2020:l7012. doi:10.1136/bmj.l7012
9. Wong S, McClaren B, Archibald A et al. A mixed methods study of age at diagnosis and diagnostic odyssey for Duchenne muscular dystrophy.European Journal of Human Genetics . 2015;23(10):1294-1300. doi:10.1038/ejhg.2014.301
10. McDonald C, Meier T, Voit T et al. Idebenone reduces respiratory complications in patients with Duchenne muscular dystrophy.Neuromuscular Disorders . 2016;26(8):473-480. doi:10.1016/j.nmd.2016.05.008
11. Lo Mauro A, Aliverti A. Physiology of respiratory disturbances in muscular dystrophies.Breathe . 2016;12(4):318-327. doi:10.1183/20734735.012716
12. Buu M. Respiratory complications, management and treatments for neuromuscular disease in children.Curr Opin Pediatr . 2017;29(3):326-333. doi:10.1097/mop.0000000000000498
13. Hoque R. Sleep-Disordered Breathing in Duchenne Muscular Dystrophy: An Assessment of the Literature.Journal of Clinical Sleep Medicine . 2016;12(06):905-911. doi:10.5664/jcsm.5898
14. Katz S, Barrowman N, Monsour A, Su S, Hoey L, McKim D. Long-Term Effects of Lung Volume Recruitment on Maximal Inspiratory Capacity and Vital Capacity in Duchenne Muscular Dystrophy. Ann Am Thorac Soc . 2015. doi:10.1513/annalsats.201507-475bc
15. Toussaint M, Pernet K, Steens M, Haan J, Sheers N. Cough Augmentation in Subjects With Duchenne Muscular Dystrophy: Comparison of Air Stacking via a Resuscitator Bag Versus Mechanical Ventilation.Respir Care . 2015;61(1):61-67. doi:10.4187/respcare.04033
16. Sheehan D, Birnkrant D, Benditt J et al. Respiratory Management of the Patient With Duchenne Muscular Dystrophy.Pediatrics . 2018;142(Supplement 2):S62-S71. doi:10.1542/peds.2018-0333h
17. Araujo A, Nardes F, Fortes C et al. Brazilian consensus on Duchenne muscular dystrophy. Part 2: rehabilitation and systemic care.Arq Neuropsiquiatr . 2018;76(7):481-489. doi:10.1590/0004-282x20180062
18. Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur A. Corticosteroids for the treatment of Duchenne muscular dystrophy.Cochrane Database of Systematic Reviews . 2016. doi:10.1002/14651858.cd003725.pub4
19. Gogou M, Pavlou E, Haidopoulou K. Therapies that are available and under development for Duchenne muscular dystrophy: What about lung function?.Pediatr Pulmonol . 2019;55(2):300-315. doi:10.1002/ppul.24605